Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Merad

Showing results (211-220 of 349) with videos related to

Pageof 35
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 4, 2025
Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activationXucheng Hou, Chang Wang, Yichen Zhong, et al.
Nature|December 25, 2014
Commensal-dendritic-cell interaction specifies a unique protective skin immune signatureShruti Naik, Nicolas Bouladoux, Jonathan L Linehan, et al.
Frontiers in Immunology|June 15, 2026
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLCKyoo Hyun Kim, Mina Han, Geon Woo Park, et al.
Journal of Autoimmunity|May 14, 2019
Interleukin-1β-induced IRAK1 ubiquitination is required for T<sub>H</sub>-GM-CSF cell differentiation in T cell-mediated inflammationYuan Hu, Feihong Xu, Ruihua Zhang, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Disease duration impacts intestinal gene expression profiles in Crohn's disease but not in ulcerative colitisSusanne Ibing, Christopher Tastad, Bernhard Y Renard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Cell|December 28, 2020
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory DiseaseJune-Yong Lee, Jason A Hall, Lina Kroehling, et al.
Multiple Sclerosis and Related Disorders|January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Cell|October 31, 2024
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGurkan Mollaoglu, Alexander Tepper, Chiara Falcomatà, et al.
Cell|December 24, 2019
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory DiseaseJune-Yong Lee, Jason A Hall, Lina Kroehling, et al.
Pageof 35

Showing results (211-220 of 349) with videos related to

Sort By:
Pageof 35
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 4, 2025
Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activationXucheng Hou, Chang Wang, Yichen Zhong, et al.
Nature|December 25, 2014
Commensal-dendritic-cell interaction specifies a unique protective skin immune signatureShruti Naik, Nicolas Bouladoux, Jonathan L Linehan, et al.
Frontiers in Immunology|June 15, 2026
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLCKyoo Hyun Kim, Mina Han, Geon Woo Park, et al.
Journal of Autoimmunity|May 14, 2019
Interleukin-1β-induced IRAK1 ubiquitination is required for T<sub>H</sub>-GM-CSF cell differentiation in T cell-mediated inflammationYuan Hu, Feihong Xu, Ruihua Zhang, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Disease duration impacts intestinal gene expression profiles in Crohn's disease but not in ulcerative colitisSusanne Ibing, Christopher Tastad, Bernhard Y Renard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Cell|December 28, 2020
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory DiseaseJune-Yong Lee, Jason A Hall, Lina Kroehling, et al.
Multiple Sclerosis and Related Disorders|January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Cell|October 31, 2024
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGurkan Mollaoglu, Alexander Tepper, Chiara Falcomatà, et al.
Cell|December 24, 2019
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory DiseaseJune-Yong Lee, Jason A Hall, Lina Kroehling, et al.
Pageof 35